Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|December 3, 1998
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donorsW J Burlingham, A P Grailer, D M Heisey, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 30, 2015
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney TransplantationN Shuker, R Bouamar, R H N van Schaik, et al.
Frontiers in Pharmacology|May 17, 2021
Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric PracticeR van Westrhenen, R H N van Schaik, T van Gelder, et al.
The Pharmacogenomics Journal|November 4, 2009
The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patientsP W Schenk, M van Vliet, R A A Mathot, et al.
Molecular Psychiatry|August 2, 2007
Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patientsP W Schenk, M A C van Fessem, S Verploegh-Van Rij, et al.
British Journal of Cancer|August 12, 2010
The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancerL A Lammers, R H J Mathijssen, T van Gelder, et al.
The Netherlands Journal of Medicine|January 31, 2018
Conversion from tacrolimus to everolimus with complete and early glucocorticoid withdrawal after kidney transplantation: a randomised trialR Bouamar, N Shuker, J A J Osinga, et al.
Clinical Pharmacology and Therapeutics|May 24, 2012
Effects of CYP induction by rifampicin on tamoxifen exposureL Binkhorst, T van Gelder, W J Loos, et al.
Pageof 12